Cargando…

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia

In early Alzheimer’s dementia, there is a need for PET biomarkers of disease progression with close associations to cognitive dysfunction that may aid to predict further cognitive decline and neurodegeneration. Amyloid biomarkers are not suitable for that purpose. The α4β2 nicotinic acetylcholine re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabri, Osama, Meyer, Philipp M, Gräf, Susanne, Hesse, Swen, Wilke, Stephan, Becker, Georg-Alexander, Rullmann, Michael, Patt, Marianne, Luthardt, Julia, Wagenknecht, Gudrun, Hoepping, Alexander, Smits, Rene, Franke, Annegret, Sattler, Bernhard, Tiepolt, Solveig, Fischer, Steffen, Deuther-Conrad, Winnie, Hegerl, Ulrich, Barthel, Henryk, Schönknecht, Peter, Brust, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972585/ https://www.ncbi.nlm.nih.gov/pubmed/29672680 http://dx.doi.org/10.1093/brain/awy099

Ejemplares similares

(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
por: Tiepolt, Solveig, et al.
Publicado: (2020)

Exploring the Metabolism of (+)-[(18)F]Flubatine In Vitro and In Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study †
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2018)

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[(11)C]methylreboxetine positron emission tomography study
por: Ulke, Christine, et al.
Publicado: (2019)

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain μ-opioid Receptor Availability in Diet-Induced Obese Male Rats
por: Hankir, Mohammed K., et al.
Publicado: (2017)

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020)

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine—A New Tracer in Clinical Translation for Imaging of σ(1) Receptors
por: Kranz, Mathias, et al.
Publicado: (2016)

Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-β
por: Bucerius, Jan, et al.
Publicado: (2017)

LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine—A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2016)

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

A novel thermoregulatory role for PDE10A in mouse and human adipocytes
por: Hankir, Mohammed K, et al.
Publicado: (2016)

JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps
por: Dukart, Juergen, et al.
Publicado: (2020)

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Huang, Jue, et al.
Publicado: (2022)

Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490
por: Rötering, Sven, et al.
Publicado: (2014)

A Promising PET Tracer for Imaging of α(7) Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand
por: Teodoro, Rodrigo, et al.
Publicado: (2015)

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients
por: Schmidt, Elisa, et al.
Publicado: (2020)

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
por: Soeder, J. Marvin, et al.
Publicado: (2021)

Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI
por: Werner, P., et al.
Publicado: (2016)

Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[(18)F]Fluspidine in Glioblastoma
por: Toussaint, Magali, et al.
Publicado: (2020)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

Preclinical Incorporation Dosimetry of [(18)F]FACH—A Novel (18)F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET
por: Sattler, Bernhard, et al.
Publicado: (2020)

Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
por: Schroeter, Matthias L., et al.
Publicado: (2015)

Citalopram Improves Obsessive-Compulsive Crossword Puzzling in Frontotemporal Dementia
por: Meyer, Sebastian, et al.
Publicado: (2019)

Preclinical Evaluation of [(18)F]FACH in Healthy Mice and Piglets: An (18)F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET
por: Gündel, Daniel, et al.
Publicado: (2021)

Fully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep model
por: Jochimsen, Thies H., et al.
Publicado: (2016)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022)

Nemacol is a small molecule inhibitor of C. elegans vesicular acetylcholine transporter with anthelmintic potential
por: Harrington, Sean, et al.
Publicado: (2023)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
por: Schröder, Susann, et al.
Publicado: (2016)

Improved in vivo PET imaging of the adenosine A(2A) receptor in the brain using [(18)F]FLUDA, a deuterated radiotracer with high metabolic stability
por: Lai, Thu Hang, et al.
Publicado: (2021)

Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice
por: Weiner, Juliane, et al.
Publicado: (2016)

Quantitation of the A(2A) Adenosine Receptor Density in the Striatum of Mice and Pigs with [(18)F]FLUDA by Positron Emission Tomography
por: Gündel, Daniel, et al.
Publicado: (2022)

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity
por: Drabe, M, et al.
Publicado: (2017)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bmmil6s35gt7vuscf90353s9ch